Work

Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified gastroesophageal junction (GEJ), gastric (G), or esophageal (E) cancer.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.1

Authors: Eunice Lee Kwak, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Daniel Virgil Thomas Catenacci, Emily Chan, Tanios S. Bekaii-Saab, Benny Amore, Yuying C. Hwang, Rui Tang, Gataree Ngarmchamnanrith, David S. Hong

Institutions: Harvard University, Massachusetts General Hospital, Yale Cancer Center, Angeles Clinic and Research Institute, The University of Texas MD Anderson Cancer Center, The Barbara Ann Karmanos Cancer Institute, University of Chicago, Vanderbilt University Medical Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Amgen (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2339993148

Cites:

Cited by: 111

Related to: 10